TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

STOCKS

Vanda Schizophrenia Drug Gets Rotten Review

  • By Adam Feuerstein
  • May 19, 2010 10:58 AM EDT
NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients
STOCKS

Biotech Stock Mailbag: Labopharm

  • By Adam Feuerstein
  • Apr 23, 2010 7:00 AM EDT
Germany Slaps PTC Therapeutics With Big Drug Price Cut
STOCKS

Biotech Stock Mailbag: Generex, Part II

  • By Adam Feuerstein
  • Mar 26, 2010 7:00 AM EDT
Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
STOCKS

Biotech Stock Mailbag Readers' Portfolio

  • By Adam Feuerstein
  • Jan 21, 2010 9:22 AM EST
Pfizer to Buy King Pharma for $3.6B Cash
STOCKS

Vanda's Fanapt Deal Just Okay: BioBuzz

  • By Adam Feuerstein
  • Oct 13, 2009 9:54 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.